Chapman, K., Pavord, I., Paggiaro, P., Sciurba, F., Bafadhel, M., Bradford, E., . . . Yancey, S. (2018). Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function. American Thoracic Society.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিChapman, K., et al. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function. American Thoracic Society, 2018.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিChapman, K., et al. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function. American Thoracic Society, 2018.